Gapping down
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- LEVI -4.5% (also increases dividend), COST -1.3% (June comps), PEP -0.9%, AVAV -0.5% (FY30 financial targets)
Other news:
- IONS -18.9% (Ionis Pharma and AstraZeneca (AZN) report Phase 3 ATTR-CM study misses primary endpoint)
- AZN -8.4% (Ionis Pharma and AstraZeneca (AZN) report Phase 3 ATTR-CM study misses primary endpoint)
- MDA -8.1% (to acquire majoirty interest in Collecte Localisation Satellites; also bought deal offering)
- ALEC -6.6% (GSK terminates collaboration)
- RDY -3.7% (discloses that certain batches of semaglutide were out of specification due to an issue associated with the active pharmaceutical ingredient used in the product)
- PERI -2% (new partnership with Acrossmedia241)
- CCNE -1.4% (files for $150 mln mixed securities shelf offering)
- BRBR -1.4% (appoints new CEO)